Company · founded 2005
Horizon Therapeutics (United States)
Lake Forest, United States · horizontherapeutics.com
- Citations, last 5 years
- 805
- Works, last 5 years
- 100
- h-index
- 52
- Scientists listed
- 3
- Grants since 2016
- 3
Grants received
2025–2026 · research · R43
Next-Generation CNS-Penetrant HDAC6 Inhibitors: Proof-of-Principle in Parkinson's Disease
Rebecca Ellen James · Horizon Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Mechanistic Validation of Selective Brain-Penetrant HDAC6 Inhibitors as a Disease- Modifying Treatment for Tauopathies including Alzheimer's Disease
Frederick Albert Schroeder · Horizon Therapeutics (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Targeting HDAC6 to Modulate Titin Stiffness for Dilated Cardiomyopathy Therapy
Frederick Albert Schroeder · Horizon Therapeutics (United States) · funded by National Institutes of Health